COVID-19 and cardiac implantable electronic device remote monitoring: crocodile tears or new opportunity?

References

• Lu R , Zhao X , Li J , et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574.
   PubMed Web of Science ®Google Scholar
• Mehra MR , Desai SS , Kuy S , et al. Cardiovascular disease, drug therapy, and mortality in Covid-19 [published online ahead of print, 2020 May 1]. N Engl J Med. 2020;NEJMoa2007621. DOI:10.1056/NEJMoa2007621
   Google Scholar
• Clerkin KJ , Fried JA , Raikhelkar J , et al. COVID-19 and cardiovascular disease. Circulation. 2020;141(20):1648‐1655.
   Web of Science ®Google Scholar
• Varma N , Epstein AE , Irimpen A , et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010 Jul 27;122(4):325–332. Epub 2010 Jul 12.
   PubMed Web of Science ®Google Scholar
• Russo V , Rago A , Tavoletta V , et al. Remote monitoring of atrial high rate episodes in pacemaker patients. The rapid study design. J Atr Fibrillation. 2018 Aug 31;11(2):2075. PMID: 30505383; PMCID: PMC6244309.
   PubMedGoogle Scholar
• García-Fernández FJ , Osca Asensi J , Romero R , et al. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE). Eur Heart J. 2019;40(23):1837‐1846.
   PubMed Web of Science ®Google Scholar
• Varma N , Michalski J , Stambler B , et al.; Investigators T . Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the trust trial-testing execution of the recommendations. Eur Heart J. 2014;35:1345–1352.
   PubMed Web of Science ®Google Scholar
• Guedon-Moreau L , Lacroix D , Sadoul N , et al. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ecost trial. Eur Heart J. 2013;34:605–614.
   PubMed Web of Science ®Google Scholar
• Hindricks G , Taborsky M , Glikson M , et al.; IN-TIME study group . Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014 Aug 16;384(9943):583–590.
   PubMed Web of Science ®Google Scholar
• Boehmer JP , Hariharan R , Devecchi FG , et al. A multisensor algorithm predicts heart failure events in patients with implanted devices: results from the MultiSENSE study. JACC Heart Fail. 2017 Mar;5(3):216–225. DOI:10.1016/j.jchf.2016.12.011
   PubMed Web of Science ®Google Scholar
• Capucci A , Santini L , Favale S , et al. Preliminary experience with the multisensor HeartLogic algorithm for heart failure monitoring: a retrospective case series report. ESC Heart Fail. 2019 Apr;6(2):308–318. Epub 2019 Jan 11.
   PubMed Web of Science ®Google Scholar
• Watanabe E , Yamazaki F , Goto T , et al. Remote management of pacemaker patients with biennial in-clinic evaluation: continuous home monitoring in the Japanese at-home study: a randomized clinical trial. Circ Arrhythm Electrophysiol. 2020;13(5):e007734.
   PubMed Web of Science ®Google Scholar
• Slotwiner D , Varma N , Akar JG , et al. HRS expert consensus statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm. 2015;12(7):e69–100.
   PubMed Web of Science ®Google Scholar
• https://www.hrsonline.org/COVID19-Challenges-Solutions/hrs-covid-19-task-force-update-april-15-2020
   Google Scholar
• Marinskis G , van Erven L , Bongiorni MG , et al.; Scientific Initiative committee, European Heart Rhythm Association . Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey. Europace. 2012 Mar;14(3):423–425.
   PubMed Web of Science ®Google Scholar
• Ricci RP , Calcagnini G , Castro A , et al. Consensus document on remote monitoring of cardiac implantable electronic devices: technology, indications, organizational models, acceptability, responsibility, and economic issues. G Ital Cardiol (Rome). 2011 Jun;12(6):450–467.
   PubMedGoogle Scholar
• Luzi M , De Simone A , Leoni L , et al. Remote monitoring for implantable defibrillators: a nationwide survey in Italy. Interact J Med Res. 2013;2(2):e27.
   PubMedGoogle Scholar
• Palmisano P , Melissano D , Zanotto G , et al. Change in the use of remote monitoring of cardiac implantable electronic devices in Italian clinical practice over a 5-year period: results of two surveys promoted by the AIAC (Italian Association of Arrhythmology and Cardiac Pacing). J Cardiovasc Med (Hagerstown). 2020 Apr;21(4):305–314.
   PubMed Web of Science ®Google Scholar